Medicare Compliance & Reimbursement - 2018 Issue 6
Compliance: Recent Medicare Audit Shows Where EDs Stand in Terms of Opioid Prescriptions
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare Comparative Billing Report from Palmetto GBA that reviews opioid prescribing patterns and benchmarking for emergency department providers. It places the report in the broader context of CMS and FDA attention to opioid-related prescribing trends and mentions related monitoring interest in gabapentinoids. The piece is relevant for emergency physicians, compliance staff, and coding/billing professionals who want to understand how peer comparisons and federal audits are being used in this area.
Why This Topic Matters
Medicare audit and benchmarking reports can identify outlier billing or prescribing patterns that may prompt compliance review. Understanding the general focus of these reports helps ED organizations assess their own utilization patterns and prepare for future monitoring efforts.
Article Sections
-
Background
Introduces the Medicare comparative billing report and the general purpose of the analysis. It also notes the federal and contractor organizations involved in producing the report.
-
EDs Rank High in One Category
Summarizes the reported benchmarking results for emergency department physicians and compares them with broader national prescribing patterns. It also discusses how providers are encouraged to interpret peer comparisons and consider internal review when needed.
-
Could Gabapentinoid Reviews Be Next?
Highlights additional federal interest in opioid-related prescribing oversight and mentions related monitoring attention toward gabapentinoids. The section frames possible future review areas without providing coding or prescribing instructions.
What You Will Learn
- How a Medicare comparative billing report is used to benchmark opioid prescribing patterns
- What broad types of provider comparisons were reviewed in the report
- Why emergency department practices may want to compare their own patterns with peer data
- What federal agencies are focusing on in opioid-related monitoring
- Why gabapentinoid prescribing may attract future review attention
Who Should Read This
- Emergency department physicians
- Medical coders and billers
- Compliance professionals
- Practice managers
- Revenue cycle staff
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com